The Rothenberg CURED Research Lab is an active member of research, professional and patient advocacy communities for allergic and eosinophilic conditions, as represented in the following videos.
Journey to the First FDA Approved Drug for EoE (2022)
Applying for the NIH Loan Repayment Program (2021)
Bridge to Next-Gen Medicine: Improving Pediatric Medicine on a Global Scale (2021).
2020 Research Highlights: Division of Allergy and Immunology (February 2021)
Learn more about the areas of research and current projects of the Rothenberg CURED Research Laboratory.
Learn more about the Cincinnati Center for Eosinophilic Disorders on the Cincinnati Children’s blog.
Learn more about research efforts on eosinophilic conditions, including news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children’s.